← Back to Search

Digital Health Platform for Insomnia

N/A
Waitlist Available
Research Sponsored by Noctem, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare three ways to use NOCTEM COAST, a decision-support platform, with behavioral health providers who see patients with insomnia.

Who is the study for?
This trial is for behavioral health care providers who have recently completed a Behavioral Sleep Medicine workshop and see patients with insomnia. Providers must use cognitive-behavioral techniques, work at participating sites, and their patients should own a smart device and be willing to use the NOCTEM app.
What is being tested?
The study compares three methods of implementing the NOCTEM COAST platform among providers treating insomnia: external facilitation support, no facilitation support, or both external and internal support. It aims to optimize how this digital tool is used in clinical practice.
What are the potential side effects?
Since this trial involves the implementation of a digital health platform rather than medication or medical procedures, traditional side effects are not applicable. However, there may be technical issues or challenges in using the app that could affect user experience.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adoption among clinicians randomized to NOCTEM only, NOCTEM+EF, or NOCTEM+EF/IF
Maintenance (sustainability) among clinicians randomized to NOCTEM only, NOCTEM+EF, or NOCTEM+EF/IF
Reach among clinicians randomized to NOCTEM only, NOCTEM+EF, or NOCTEM+EF/IF

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: External and Internal Facilitation (NOCTEM+EF/IF)Active Control1 Intervention
External and internal facilitation
Group II: External Facilitation (NOCTEM+EF)Active Control1 Intervention
External facilitation only
Group III: NOCTEM only (NOCTEM)Active Control1 Intervention
No external or internal facilitation

Find a Location

Who is running the clinical trial?

Noctem, LLCLead Sponsor
1 Previous Clinical Trials
188 Total Patients Enrolled
United States Department of DefenseFED
906 Previous Clinical Trials
333,353 Total Patients Enrolled
US Air Force Medical Readiness AgencyUNKNOWN
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top